NLRP3 Cancer Research Results
NLRP3, NOD-like receptor pyrin domain-containing protein 3: Click to Expand ⟱
| Source: |
| Type: |
NLRP3 (NOD-like receptor pyrin domain-containing protein 3) is a protein that plays a crucial role in the regulation of inflammation and immune responses.
NLRP3 typically has high expression in cancers, with poor prognosis.
For alzheimer's disease:
-NLRP3 is upregulated in Alzheimer's disease (AD)
-NLRP3 is activated in microglia in response to amyloid-β (Aβ) and tau aggregates.
-Promotes tau hyperphosphorylation and spread via inflammation-driven pathways.
|
Stroke, Cerebral Ischemic Stroke: Click to Expand ⟱
Ischemic stroke is also called brain ischemia and cerebral ischemia. Ischemia is the medical term for "lack of blood supply."
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*neuroP↑, *antiOx↑, *Inflam↓, *BioAv↝, *BioAv↑, *Half-Life↝, *TLR4↓, *NF-kB↓, *iNOS↓, *COX2↓, *TNF-α↓, *12LOX↓, *NLRP3↓, *ROS↓, *IL1β↓, *IL6↓, *GSK‐3β↓, *NRF2↑, *BBB↑, *SOD↑, *GPx↑, *MDA↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*antiOx↓, *ROS↑, *SOD↑, *GSH↑, *NRF2↑, *MDA↓, *HNE↓, *Inflam↓, *MAPK↓, *IL6↓, *TNF-α↓, *HO-1↑, *cardioP↑, *neuroP↑, *CRM↑, *NLRP3↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*MitoP↑, *Inflam↓, *antiOx↑, *Risk↓, *Aβ↓, *p‑tau↓, *p62↓, *PARK2↑, *MMP↑, *ROS↓, *Strength↑, *CRP↓, *IL1β↓, *IL6↓, *TNF-α↓, *AMPK↑, *NF-kB↓, *MAPK↓, *p62↑, *NRF2↑, *SOD↑, *Catalase↑, *HO-1↑, *Ferroptosis↓, *lipid-P↓, *Cartilage↑, *PI3K↓, *Akt↓, *mTOR↓, *Apoptosis↓, *neuroP↑, *Bcl-2↓, *BAX↑, *Casp3↑, *ATP↑, *eff↑, *motorD↑, *NLRP3↓, *radioP↑, *BBB↑,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Total Targets: 0
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↓, 1, antiOx↑, 2, Catalase↑, 1, Ferroptosis↓, 1, GPx↑, 1, GSH↑, 1, HNE↓, 1, HO-1↑, 2, lipid-P↓, 1, MDA↓, 2, NRF2↑, 3, PARK2↑, 1, ROS↓, 2, ROS↑, 1, SOD↑, 3,
Mitochondria & Bioenergetics ⓘ
ATP↑, 1, MMP↑, 1,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, AMPK↑, 1, CRM↑, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↓, 1, BAX↑, 1, Bcl-2↓, 1, Casp3↑, 1, Ferroptosis↓, 1, iNOS↓, 1, MAPK↓, 2,
Autophagy & Lysosomes ⓘ
MitoP↑, 1, p62↓, 1, p62↑, 1,
Proliferation, Differentiation & Cell State ⓘ
GSK‐3β↓, 1, mTOR↓, 1, PI3K↓, 1,
Migration ⓘ
Cartilage↑, 1,
Barriers & Transport ⓘ
BBB↑, 2,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, CRP↓, 1, IL1β↓, 2, IL6↓, 3, Inflam↓, 3, NF-kB↓, 2, TLR4↓, 1, TNF-α↓, 3,
Synaptic & Neurotransmission ⓘ
p‑tau↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1, NLRP3↓, 3,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, BioAv↝, 1, eff↑, 1, Half-Life↝, 1,
Clinical Biomarkers ⓘ
CRP↓, 1, IL6↓, 3,
Functional Outcomes ⓘ
cardioP↑, 1, motorD↑, 1, neuroP↑, 3, radioP↑, 1, Risk↓, 1, Strength↑, 1,
Total Targets: 59
Scientific Paper Hit Count for: NLRP3, NOD-like receptor pyrin domain-containing protein 3
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:36 Cells:% prod#:% Target#:908 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page